SCHEMBL985197

SCHEMBL985197

O=Cc1cccc2c(C=O)c3ccccc3cc12

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ERN1 O75460 4/20 0.46
TDP1 Q9NUW8 2/20 0.43
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
LMNA P02545 1/20 0.43
THRB P10828 1/20 0.43
BLM P54132 1/20 0.43
PADI4 Q9UM07 1/20 0.41
MAPT P10636 3/20 0.39
CYP1A2 P05177 2/20 0.39
CYP2C9 P11712 2/20 0.39
CYP2C19 P33261 1/20 0.39
ALDH1A1 P00352 3/20 0.39
HIF1A Q16665 1/20 0.39
CYP1B1 Q16678 1/20 0.39
HSD17B10 Q99714 1/20 0.39
CYP2A6 P11509 4/20 0.38
L3MBTL1 Q9Y468 2/20 0.37
RAB9A P51151 2/20 0.37
NPC1 O15118 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11176243 0.89 ERN1 (0.50) ERN1TDP1MEN1KMT2ALMNA
SCHEMBL11593086 0.86 ERN1 (0.51) ERN1TDP1MEN1KMT2ALMNA
SCHEMBL31317593 0.86 ERN1 (0.43) ERN1TDP1MEN1KMT2ALMNA
SCHEMBL10348702 0.84 ERN1 (0.55) ERN1TDP1MEN1KMT2ALMNA
SCHEMBL29388184 0.82 ERN1 (0.57) ERN1TDP1MEN1KMT2ALMNA
SCHEMBL342278 0.82 ERN1 (0.57) ERN1TDP1MEN1KMT2ALMNA
Benzaldehyde SCHEMBL28242651 0.82 ALDH1A1 (0.44) ERN1TDP1MEN1KMT2ALMNA
SCHEMBL39718 0.80 ALDH1A1 (0.50) ERN1TDP1MEN1KMT2ALMNA
SCHEMBL29392367 0.80 ALDH1A1 (0.50) ERN1TDP1MEN1KMT2ALMNA
SCHEMBL10488197 0.80 MEN1 (0.41) ERN1TDP1MEN1KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8507896-B2 Compounds having electroluminescent or electron transport properties MERCK PATENT GMBH (DE) 2013-08-13 US claimed
US-20110006295-A1 COMPOUNDS HAVING ELECTROLUMINESCENT OR ELECTRON TRANSPORT PROPERTIES MERCK PATENT GMBH 2011-01-13 US claimed
EP-2250151-A1 COMPOUNDS HAVING ELECTROLUMINESCENT OR ELECTRON TRANSPORT PROPERTIES Merck Patent GmbH (DE) 2010-11-17 EP claimed
WO-2009112854-A1 COMPOUNDS HAVING ELECTROLUMINESCENT OR ELECTRON TRANSPORT PROPERTIES MERCK PATENT GMBH (DE) 2009-09-17 WO claimed
CN-111116528-B Method for producing aromatic primary diamine 罗地亚经营管理公司 2023-08-01 CN disclosed
US-11066377-B2 Process for producing aromatic primary diamines RHODIA OPERATIONS (FR) 2021-07-20 US disclosed
US-10899726-B2 Process for producing aromatic primary diamines RHODIA OPERATIONS (FR) 2021-01-26 US disclosed
EP-3674285-A1 PROCESS FOR PRODUCING M-XYLYLENEDIAMINE RHODIA OPERATIONS (FR) 2020-07-01 EP disclosed
US-20200172501-A1 PROCESS FOR PRODUCING AROMATIC PRIMARY DIAMINES SPECIALTY OPERATIONS FRANCE (FR) 2020-06-04 US disclosed
CN-111116528-A Process for producing aromatic primary diamines 罗地亚经营管理公司 2020-05-08 CN disclosed
EP-3166921-B1 PROCESS FOR PRODUCING AROMATIC PRIMARY DIAMINES RHODIA OPERATIONS (FR) 2020-02-19 EP disclosed
CN-106488905-B Process for producing aromatic primary diamines 罗地亚经营管理公司 2019-12-17 CN disclosed
US-20170217916-A1 PROCESS FOR PRODUCING AROMATIC PRIMARY DIAMINES SPECIALTY OPERATIONS FRANCE (FR) 2017-08-03 US disclosed
EP-3166921-A1 PROCESS FOR PRODUCING AROMATIC PRIMARY DIAMINES Rhodia Operations (FR) 2017-05-17 EP disclosed
WO-2016004867-A1 PROCESS FOR PRODUCING AROMATIC PRIMARY DIAMINES RHODIA OPERATIONS (FR) 2016-01-14 WO disclosed
US-8507896-B2 Compounds having electroluminescent or electron transport properties MERCK PATENT GMBH (DE) 2013-08-13 US disclosed
US-20110006295-A1 COMPOUNDS HAVING ELECTROLUMINESCENT OR ELECTRON TRANSPORT PROPERTIES MERCK PATENT GMBH 2011-01-13 US disclosed
EP-2250151-A1 COMPOUNDS HAVING ELECTROLUMINESCENT OR ELECTRON TRANSPORT PROPERTIES Merck Patent GmbH (DE) 2010-11-17 EP disclosed
WO-2009112854-A1 COMPOUNDS HAVING ELECTROLUMINESCENT OR ELECTRON TRANSPORT PROPERTIES MERCK PATENT GMBH (DE) 2009-09-17 WO disclosed
WO-1980002424-A1 SUBSTITUTED 9,10-ANTHRACENE-BYSHYDRAZONES AMERICAN CYANAMID CO (US) 1980-11-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110006295-A1 COMPOUNDS HAVING ELECTROLUMINESCENT OR ELECTRON TRANSPORT PROPERTIES NR2E3, NR4A2, NR4A3 ERN1 2585/4885TDP1 3183/4885MEN1 4165/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.